0% found this document useful (0 votes)
6 views1 page

Tuberculosis Disease Literature Review

Tuberculosis (TB) is a bacterial infection primarily affecting the lungs, transmitted through the air by infected individuals. Symptoms include a persistent cough, fever, and weight loss, with diagnosis confirmed through medical tests. Treatment involves a long course of antibiotics, but challenges such as multidrug-resistant strains and socio-economic factors complicate control efforts, highlighting the need for improved therapies and vaccines.

Uploaded by

timothy.sawanda
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
6 views1 page

Tuberculosis Disease Literature Review

Tuberculosis (TB) is a bacterial infection primarily affecting the lungs, transmitted through the air by infected individuals. Symptoms include a persistent cough, fever, and weight loss, with diagnosis confirmed through medical tests. Treatment involves a long course of antibiotics, but challenges such as multidrug-resistant strains and socio-economic factors complicate control efforts, highlighting the need for improved therapies and vaccines.

Uploaded by

timothy.sawanda
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Tuberculosis (TB) Literature Review

timtheesam@[Link]

Write a literature review on Tuberculosis disease

Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis that primarily affects the
lungs, but can also spread to other parts of the body. The disease is spread through the air when an
infected person coughs, sneezes, or talks, releasing droplets containing the bacteria into the air.

Symptoms of TB include a persistent cough, fever, night sweats, weight loss, and chest pain. The
diagnosis of TB is confirmed by a combination of medical history, physical examination, chest X-ray, and
laboratory tests including sputum analysis and a skin test called the Mantoux test.

Treatment for TB typically involves a combination of antibiotics taken for at least 6 to 9 months. The
World Health Organization recommends the use of directly observed therapy (DOT) to ensure that
patients take their medication as prescribed. Multidrug-resistant TB (MDR-TB) and extensively drug-
resistant TB (XDR-TB) are strains of the disease that are resistant to multiple drugs, making treatment
more complex and less effective.

The global burden of TB remains high, with an estimated 10 million new cases and 1.5 million deaths in
2020. Factors that contribute to the spread of TB include poverty, poor housing conditions, and a weak
immune system due to diseases such as HIV/AIDS.

Efforts to control the spread of TB include increased access to testing and treatment, improved infection
control measures in healthcare settings, and development of a vaccine. Currently, there is only one
vaccine for TB, the Bacillus Calmette-Guerin (BCG) vaccine, which is not highly effective and is primarily
given to infants in high-burden countries.

In conclusion, TB continues to be a significant public health issue, particularly in low- and middle-income
countries. The development of new and more effective drugs, as well as a more effective vaccine, are
crucial for reducing the global burden of the disease.

Common questions

Powered by AI

Diagnostic methods for confirming TB include medical history evaluation, physical examination, chest X-ray, sputum analysis, and the Mantoux skin test. In low-resource settings, challenges like lack of access to laboratory facilities, trained personnel, and expensive costs can hinder the effective application of these diagnostics, affecting timely and accurate diagnosis and treatment initiation .

Socioeconomic factors play a significant role in the spread of Tuberculosis (TB) as poverty, poor housing conditions, and limited access to healthcare increase vulnerability to infection. These factors contribute to high transmission rates due to overcrowded living environments and weaken the ability of individuals to seek adequate and timely medical care, perpetuating the cycle of infection and poverty .

Global health organizations like the World Health Organization (WHO) play a vital role in combating TB by setting international health standards, providing technical support to countries, financing TB control measures, and facilitating coordination among stakeholders. They have implemented strategies such as the DOTS framework for treatment adherence, promoting research for new diagnostics and treatments, and advocating for socioeconomic interventions to reduce TB risk factors .

The limitations of the Bacillus Calmette-Guerin (BCG) vaccine in controlling TB include its limited effectiveness, primarily in preventing severe forms of TB in infants rather than pulmonary TB in adults. This limitation affects global health strategies since reliance on the BCG vaccine alone is insufficient for controlling TB pandemics. Hence, there is a critical need for developing new vaccines to achieve better control of TB spread globally .

A weakened immune system, often due to diseases such as HIV/AIDS, increases susceptibility to TB by reducing the body's ability to fight off the Mycobacterium tuberculosis bacteria. This vulnerability not only causes faster progression of the disease but also facilitates its spread, as individuals with compromised immunity are more likely to become carriers and transmitters of TB .

Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) complicate treatment protocols as they are resistant to multiple standard TB drugs, making them harder and more costly to treat. This resistance necessitates the use of alternative, often more toxic and expensive antibiotics over longer periods. Consequently, the treatment success rates are lower, and patient management becomes more complex, impacting healthcare systems heavily .

The Directly Observed Therapy (DOT) strategy is important in TB treatment as it ensures patients adhere to their medication regimes, critical in preventing the development of drug-resistant strains like MDR-TB and XDR-TB. By having healthcare workers observe patients taking their medication, DOT improves treatment success rates and reduces the risk of transmission, particularly in regions with high TB burdens .

Developing new TB vaccines and drugs is significant for tackling the global TB epidemic as current tools, including the BCG vaccine, offer limited protection and drug-resistant strains pose treatment challenges. Innovative vaccines and medications could improve prevention and treatment success rates, manage drug-resistant cases more effectively, and ultimately reduce the global TB burden, particularly in high-incidence regions .

Potential public health strategies to reduce the global burden of TB include increasing access to testing and treatment, enhancing infection control measures in healthcare settings, investing in research for new and effective drugs and vaccines, and improving socioeconomic conditions such as housing and nutrition. Education on TB prevention and promoting health awareness can also play a critical role in controlling the spread of the disease .

The primary transmission methods of Tuberculosis (TB) are through the air when an infected person coughs, sneezes, or talks, releasing droplets containing the bacteria. Controlling these transmission methods is crucial for public health because TB can easily spread among people sharing close spaces, especially in conditions of poverty and poor housing. Effective control measures can reduce the incidence of TB and prevent outbreaks, particularly in high-burden settings .

You might also like